Biomarker Testing and DNA Collection in Subjects Participating in an Open-Label, Flexible-Dose Evaluation of the Efficacy, Safety, and Tolerability of STX209 in the Treatment of Irritability in Subjects With Autism Spectrum Disorders
Latest Information Update: 14 Aug 2013
At a glance
- Drugs Arbaclofen (Primary)
- Indications Irritability; Pervasive child development disorders
- Focus Biomarker; Pharmacodynamics; Pharmacogenomic
- 14 Aug 2013 New trial record